FLINT, Mich. — Diplomat Pharmacy raised almost $200 million Tuesday following the closing of its follow-on public offering of 9.8 million shares of common stock at a price to the public of $29 per share. Diplomat sold 6.8 million shares of common stock and certain shareholders of Diplomat sold 3 million shares of common stock.
Diplomat will not receive any proceeds from shares of common stock sold by the selling shareholders.
Credit Suisse Securities and Morgan Stanley acted as lead book-running managers. Additional book-running managers were J.P. Morgan Securities and Wells Fargo Securities. William Blair & Company, Leerink Partners and Raymond James & Associates acted as co-managers.